ConductScience.org, home

Paper40428282

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).

Englisz A and 5 others. Diagnostics (Basel), 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review). Papers, record 40428282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40428282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).
PubMed
Journal
Diagnostics (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.71, provisional
iCite
Revised in PubMed
2025-05-31
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Englisz AAleksandra
2Smycz-Kubańska MMartahttps://orcid.org/0000-0003-4110-5258
3Królewska-Daszczyńska PPatrycja
4Błaut MMagdalena
5Duszyc AAgnieszka
6Mielczarek-Palacz AAleksandrahttps://orcid.org/0000-0001-8528-1494

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19170483Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.Obstet Gynecol1997https://conductscience.org/library/papers/9170483PubMed
233536036Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.J Transl Med2021https://conductscience.org/library/papers/33536036PubMed
335545786Potential clinical utility of liquid biopsies in ovarian cancer.Mol Cancer2022https://conductscience.org/library/papers/35545786PubMed
415111296Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.Am J Pathol2004https://conductscience.org/library/papers/15111296PubMed
532176625Utility of urinary ctDNA to monitoring minimal residual disease in early breast cancer patients.Cancer Biomark2020https://conductscience.org/library/papers/32176625PubMed
635303879Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.Mol Cancer2022https://conductscience.org/library/papers/35303879PubMed
735138400Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.JAMA Netw Open2022https://conductscience.org/library/papers/35138400PubMed
839335089The Role of Circulating Tumor DNA in Ovarian Cancer.Cancers (Basel)2024https://conductscience.org/library/papers/39335089PubMed
938414861PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer.iScience2024https://conductscience.org/library/papers/38414861PubMed
1034111149Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer.PLoS One2021https://conductscience.org/library/papers/34111149PubMed
1134022731HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.ESMO Open2021https://conductscience.org/library/papers/34022731PubMed
1238572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1334887451Endometrial cancer.Nat Rev Dis Primers2021https://conductscience.org/library/papers/34887451PubMed
1430319183Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review.Indian J Clin Biochem2018https://conductscience.org/library/papers/30319183PubMed
1516137751Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Gynecol Oncol2006https://conductscience.org/library/papers/16137751PubMed
1637972346Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.J Clin Oncol2024https://conductscience.org/library/papers/37972346PubMed
1720368574Development of a multimarker assay for early detection of ovarian cancer.J Clin Oncol2010https://conductscience.org/library/papers/20368574PubMed
1829416824The dawn of the liquid biopsy in the fight against cancer.Oncotarget2018https://conductscience.org/library/papers/29416824PubMed
1927054934Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.Obstet Gynecol2016https://conductscience.org/library/papers/27054934PubMed
2036208860Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer.Biomed J2023https://conductscience.org/library/papers/36208860PubMed

See all 102 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42857018Beyond molecular classification: integrating signaling, subcellular, and immune reprogramming in endometrial cancer.Front Oncol2026https://conductscience.org/library/papers/42857018PubMed
42259736Using cell-free DNA tumor methylation score to detect and monitor cholangiocarcinoma.HPB (Oxford)2026https://conductscience.org/library/papers/42259736PubMed
42073573Biomarkers with Therapeutic or Prognostic Applications in Gynecologic Malignancies.Cancers (Basel)2026https://conductscience.org/library/papers/42073573PubMed
41683910Glycomic Insights in Gynecological Disease: From Molecular Mechanisms to Precision Diagnostics and Therapeutics.Int J Mol Sci2026https://conductscience.org/library/papers/41683910PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40428282

GET https://conductscience.org/api/papers/v1/40428282/references?page=2